Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Tocque

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Molecular and Cellular Biology|June 1, 1996
A Ras-GTPase-activating protein SH3-domain-binding proteinF Parker, F Maurier, I Delumeau, et al.
Oncogene|January 1, 1993
The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cellsI Barlat, F Schweighoffer, M C Chevallier-Multon, et al.
Journal of Neurochemistry|April 1, 1984
Desipramine elicits the expression of opiate receptors and sulfogalactosylceramide synthesis in rat C6 glioma cellsB Tocque, S Albouz, J M Boutry, et al.
Oncogene|June 1, 1993
Identification of a human guanine nucleotide-releasing factor (H-GRF55) specific for Ras proteinsF Schweighoffer, M Faure, I Fath, et al.
Molecular and Cellular Biology|June 25, 1998
A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stabilityI E Gallouzi, F Parker, K Chebli, et al.
Oncogene|February 2, 1999
Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragmentsC Caron de Fromentel, N Gruel, C Venot, et al.
Journal of Medicinal Chemistry|March 18, 1994
Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactionsH Chen, J Boiziau, F Parker, et al.
Anti-Cancer Drug Design|January 1, 1996
Synthesis and biological evaluation of a series of hydroxybenzylphenylamine derivatives as inhibitors of EGF receptor-associated tyrosine kinase activityH Chen, G Bashiardes, P Mailliet, et al.
FEBS Letters|May 1, 1998
hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activityA Saltzman, G Searfoss, C Marcireau, et al.
Anti-Cancer Drug Design|March 1, 1996
Synthesis and biological evaluation of a new series of phenylhydroquinone derivatives as inhibitors of EGF-R-associated PTK activityM E Million, P Mailliett, H Chen, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Molecular and Cellular Biology|June 1, 1996
A Ras-GTPase-activating protein SH3-domain-binding proteinF Parker, F Maurier, I Delumeau, et al.
Oncogene|January 1, 1993
The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cellsI Barlat, F Schweighoffer, M C Chevallier-Multon, et al.
Journal of Neurochemistry|April 1, 1984
Desipramine elicits the expression of opiate receptors and sulfogalactosylceramide synthesis in rat C6 glioma cellsB Tocque, S Albouz, J M Boutry, et al.
Oncogene|June 1, 1993
Identification of a human guanine nucleotide-releasing factor (H-GRF55) specific for Ras proteinsF Schweighoffer, M Faure, I Fath, et al.
Molecular and Cellular Biology|June 25, 1998
A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stabilityI E Gallouzi, F Parker, K Chebli, et al.
Oncogene|February 2, 1999
Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragmentsC Caron de Fromentel, N Gruel, C Venot, et al.
Journal of Medicinal Chemistry|March 18, 1994
Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactionsH Chen, J Boiziau, F Parker, et al.
Anti-Cancer Drug Design|January 1, 1996
Synthesis and biological evaluation of a series of hydroxybenzylphenylamine derivatives as inhibitors of EGF receptor-associated tyrosine kinase activityH Chen, G Bashiardes, P Mailliet, et al.
FEBS Letters|May 1, 1998
hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activityA Saltzman, G Searfoss, C Marcireau, et al.
Anti-Cancer Drug Design|March 1, 1996
Synthesis and biological evaluation of a new series of phenylhydroquinone derivatives as inhibitors of EGF-R-associated PTK activityM E Million, P Mailliett, H Chen, et al.
Pageof 5